Angela Wahl

University of North Carolina at Chapel Hill — United States

Immunology and Microbiology · Life Sciences

26h-index3.8kcitations81works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(33), Immune Cell Function and Interaction(15), HIV/AIDS Research and Interventions(14), Immunotherapy and Immune Responses(10), T-cell and B-cell Immunology(9)

Publications81 total

SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation
Nature Microbiology·2025· 1 citedOpen Access
Envelope-dimer epitope 1 (EDE1) antibody (C10) treatment significantly reduces Zika virus replication in the male and female reproductive tracts
Journal of Virology·2025Open Access
Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
UNC Libraries·2025Open Access
Humanized Mouse Systems to Study Viral Infection: A New Era in Immunology Research
Annual Review of Immunology·2025· 3 citedOpen Access
A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection
UNC Libraries·2024· 2 citedOpen Access
RSV infection of humanized lung-only mice induces pathological changes resembling severe bronchiolitis and bronchopneumonia
UNC Libraries·2024Open Access
RSV infection of humanized lung-only mice induces pathological changes resembling severe bronchiolitis and bronchopneumonia
Frontiers in Virology·2024· 2 citedOpen Access
Transient CD4+ T cell depletion during suppressive ART reduces the HIV reservoir in humanized mice
PLoS Pathogens·2023· 11 citedOpen Access
A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection
Nature Biotechnology·2023· 29 citedOpen Access
An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity
Journal of Clinical Investigation·2023· 24 citedOpen Access
Loss of In Vivo Replication Fitness of HIV-1 Variants Resistant to the Tat Inhibitor, dCA
UNC Libraries·2023Open Access
Human T cells efficiently control RSV infection
JCI Insight·2023· 35 citedOpen Access
Loss of In Vivo Replication Fitness of HIV-1 Variants Resistant to the Tat Inhibitor, dCA
Viruses·2023· 7 citedOpen Access
HIV infection of non-classical cells in the brain
Retrovirology·2023· 49 citedOpen Access
Author Correction: Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
Nature Biotechnology·2022· 4 citedOpen Access
HIV Co-infection Augments EBV-Induced Tumorigenesis in vivo
UNC Libraries·2022Open Access
HIV Co-infection Augments EBV-Induced Tumorigenesis in vivo
Frontiers in Virology·2022· 15 citedOpen Access
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
Nature·2021· 418 citedOpen Access
Hypogammaglobulinemia in BLT Humanized Mice – An Animal Model of Primary Antibody Deficiency
UNC Libraries·2020Open Access
Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection
UNC Libraries·2020Open Access
page 1 of 5Next →

Frequent Co-authors

J. Víctor García(36), Chandrav De(12), Rae Ann Spagnuolo(12), Paul W. Denton(11), Tomonori Nochi(10), Martina Kovářová(9), David M. Margolis(9), William H. Hildebrand(8), Wenbo Yao(7), Raymond J. Pickles(7), William O. Thayer(6), Baolin Liao(6), Guido Silvestri(6), Michael D. Swanson(6), Ralph S. Baric(5), Rachel A. Cleary(5), Rikke Olesen(5), Morgan Chateau(5), Christian R. Aguilera-Sandoval(5), Francisco Martinez-Torres(5)